Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Mansouri

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
American Journal of Hematology|October 30, 2019
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphomaMaysaa Abdulla, Peter Hollander, Tatjana Pandzic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic LeukemiaTatjana Pandzic, Jimmy Larsson, Liqun He, et al.
Frontiers in Oncology|February 23, 2023
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrationsElisavet Vlachonikola, Nikolaos Pechlivanis, Georgios Karakatsoulis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
British Journal of Haematology|April 15, 2014
The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptorsJitka Malcikova, Evangelia Stalika, Zadie Davis, et al.
Clinical Epigenetics|December 4, 2019
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapyMaria Tsagiopoulou, Nikos Papakonstantinou, Theodoros Moysiadis, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
American Journal of Hematology|October 30, 2019
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphomaMaysaa Abdulla, Peter Hollander, Tatjana Pandzic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic LeukemiaTatjana Pandzic, Jimmy Larsson, Liqun He, et al.
Frontiers in Oncology|February 23, 2023
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrationsElisavet Vlachonikola, Nikolaos Pechlivanis, Georgios Karakatsoulis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
British Journal of Haematology|April 15, 2014
The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptorsJitka Malcikova, Evangelia Stalika, Zadie Davis, et al.
Clinical Epigenetics|December 4, 2019
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapyMaria Tsagiopoulou, Nikos Papakonstantinou, Theodoros Moysiadis, et al.
Pageof 7